Skeletal muscle depletion is associated with disease progression during neo-adjuvant therapy for borderline resectable pancreatic adenocarcinoma

被引：0
|
作者：
Griffin, O. M.
Ryan, R.
Duggan, S. N.
Geoghegan, J.
Conlon, K. C.
机构：
[1] Trinity Coll Dublin, Dept Surg, Trinity Ctr Hlth Sci, Natl Surg Ctr Pancreat Canc, Dublin, Ireland
[2] St Vincents Univ Hosp, Dept Radiol, Dublin, Ireland
来源：
IRISH JOURNAL OF MEDICAL SCIENCE | 2017年 / 186卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
13
引用
收藏
页码：S76 / S77
页数：2
相关论文
共 31 条
  • [1] Neo-adjuvant FOLFIRINOX in borderline resectable and locally advanced pancreatic adenocarcinoma
    Temraz, Sally
    Nassar, Farah
    Hammoud, Miza Salim
    Mukherji, Deborah
    O'Reilly, Eileen M.
    Dbouk, Haifa
    Farhat, Fadi
    Charafeddine, Maya
    Faraj, Walid
    Khalifeh, Mohammad J.
    Abou-Alfa, Ghassan K.
    Shamseddine, Ali
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 (06) : 735 - 742
  • [2] Neo-adjuvant FOLFIRINOX in borderline-resectable/locally advanced pancreatic adenocarcinoma
    Temraz, S.
    Albonji, W.
    Charafeddine, M.
    Farhat, Z.
    Mukherji, D.
    Shamseddine, A.
    ANNALS OF ONCOLOGY, 2016, 27 : 95 - 95
  • [3] Neo-adjuvant FOLFIRINOX in borderline-resectable/locally advanced pancreatic adenocarcinoma: An updated analysis
    Temraz, S.
    Hammoud, M. Salim
    Zorkot, M.
    Albonji, W.
    Dbouk, H.
    Farhat, F.
    Charafeddine, M.
    Mukherji, D.
    Shamseddine, A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [4] Neo-adjuvant Chemoradiation for Borderline Resectable Pancreatic Adenocarcinoma: A UK Tertiary Surgical Oncology Centre Series
    Likos-Corbett, Marina
    Patel, Pranav
    Goburdhun, Rachna
    Mudan, Satvinder
    Khan, Amir
    Kumar, Sacheen
    Bhogal, Ricky
    BRITISH JOURNAL OF SURGERY, 2021, 108
  • [5] Role of laparoscopy in neo-adjuvant therapy for pancreatic adenocarcinoma
    Sasson, A.
    Are, C.
    Ly, Q.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 : S91 - S91
  • [6] Surgical resectability after neo-adjuvant FOLFIRINOX for borderline or locally advanced pancreatic adenocarcinoma
    Alline, Mathias
    Colombo, Pierre Emmanuel
    Quenet, Francois
    Jarlier, Marta
    Portales, Fabienne
    Llacer, Carmen
    Fabre, Jean Michel
    Ychou, Marc
    Rouanet, Philippe
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [7] Is it necessary to perform a surgery after neo-adjuvant treatment for initially borderline or locally advanced pancreatic adenocarcinoma?
    Andre, Thierry
    Paye, Francois
    BULLETIN DU CANCER, 2015, 102 (06) : S111 - S112
  • [8] Neo-adjuvant Therapy (NAT) for Pancreatic Ductal Adenocarcinoma (PDAC) and Improvement in Glycemic Parameters
    Vasavada, S.
    Khan, A.
    Chari, S. T.
    PANCREAS, 2021, 50 (07) : 1106 - 1106
  • [9] Outcome of patients with pancreatic adenocarcinoma with complete pathological response following neo-adjuvant therapy
    Kourie, H. R.
    Cunha, A. Sa
    Pernot, S.
    Coriat, R.
    Sauvanet, A.
    Regenet, N.
    Louafi, S.
    Bachet, J-B.
    Pietrasz, D.
    Taieb, J.
    ANNALS OF ONCOLOGY, 2017, 28
  • [10] Neo-adjuvant chemotherapy followed by radical resection for primary borderline resectable unicentric Castleman disease: a case report
    Zhuang, Hongkai
    Ma, Zuyi
    Wu, Yanxia
    Yin, Zi
    Jian, Zhixiang
    Zhang, Chuanzhao
    Hou, Baohua
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (04) : 3030 - 3033
1234